The Sputnik Light Covid-19 vaccine will be launched in India by December this year. This was stated by the CEO of Russian Direct Investment Fund,  (RDIF), Kirill Dmitriey.

He said, "We are hopeful for the launch of Sputnik Light in India in December and we are working with Indian companies for the same."

"We have Serum Institute as our production partner in India, and we believe that Sputnik Light will play a big role in the Indian vaccination campaign," he added.

Sputnik Light vaccine is based on human adenovirus serotype 26, which is the first component of the Sputnik V vaccine. The single-dose vaccine has also been approved in San Marino as a booster shot for all vaccines administered in the country.

One-shot Sputnik Light is a highly effective vaccine when used both on standalone basis and applied as a booster

A one-shot vaccination regimen of Sputnik Light has a number of key advantages, including ease of administering the vaccine, monitoring and more flexible re-vaccination schedule when used as a booster.

Sputnik Light has demonstrated a superior efficacy compared with some two-shot vaccines, which have shown a major decline in efficacy against the Delta variant to less than 50% five months after injection. Standalone use of Sputnik Light also provides much higher efficacy against severe disease and hospitalizations.

Earlier in the day, the Sputnik V informed that Russia's Health Ministry will register the Sputnik vaccine for children aged 12-17, with shots expected to be available at the end of December.

"Russia's Health Ministry will register Sputnik vaccine for children aged 12-17 today. Sputnik M vaccine for children will be a welcome member in the Sputnik family both in Russia and in global markets," Sputnik V said in a tweet.